RESEARCHER PROFILE (Filmed January 2024)
Laureate Professor Clare Collins AO
Nutrition and Dietetics in the School of Health Sciences,
University of Newcastle & Director, Food and Nutrition Research Program
Hunter Medical Research Institute
New South Wales, Australia
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
Prof Collins is Laureate Professor in Nutrition and Dietetics in the School of Health Sciences, College of Health, Medicine and Wellbeing. She has received three prestigious NHMRC Research Fellowships, is currently Director of Hunter Medical Research Institute, Food and Nutrition Program and been a dietitian for over 40 years.
Laureate Professor Collins has made major contributions to our knowledge on the impact of improving diet quality and food patterns on health and wellbeing outcomes. Her research in precision and personalised nutrition is driving a paradigm shift in technologies that improve delivery of medical nutrition therapy to under-served groups based on life-stage, socio-economic status or geographic location, for whom the chronic disease burden is 40-50% higher. This is generating new knowledge on cost-effective models of care that are available online or can be embedded in health settings.
Her passion was fuelled growing up as one of nine children and being in the first generation of her family to have the opportunity complete year 12 and go to university. She learnt from an early age the meaning of hard work, the importance of grasping opportunities when they arose and the importance of share the fruits of those opportunities.
Laureate Professor Collins is a Fellow of four prestigious bodies, the Australian Academy of Health and Medical Sciences, the Nutrition Society of Australia, Dietitians Australia, and the Royal Society of NSW. As the most successful research dietitian globally, her team includes dietitians, nutritionists, biochemists, computer scientists, biomedical engineers and software developers.
She has been awarded over $29 million dollars in research grants, published over 450 manuscripts and supervised 35 PhD and Master candidates to completion so far. Laureate Professor Collins is a great believer in sharing her knowledge through translation of nutrition science to benefit the public.
You Might also like
-
Big data to improve the use of antidepressant medicines in aged care
Georgina Hughes is a pharmacist & PhD Candidate with the University of South Australia Clinical and Health Sciences and the Registry of Senior Australians (ROSA), undertaking research at South Australian Health and Medical Research Institute (SAHMRI).
Georgina’s PhD study and first published paper was on how to improve the safe and effective use of antidepressant medicines and optimise quality use of medicines in older people accessing residential aged care.
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
-
Liver cancer biomarkers, risk prediction & progression
Dr. Rodrigo Carlessi is an expert in Cancer Genomics and Molecular Biology, with an extensive track record in liver cancer research. He leads the Cancer Genomics Group within the Liver Disease and Regeneration Laboratory at the Curtin Medical Research Institute. He has an impressive publication record, with 43 manuscripts that have collectively garnered over 2,680 citations. His research leverages cutting-edge genomics and transcriptomics technologies, as well as long-read DNA sequencing, to explore mechanisms, identify biomarkers, and develop therapeutic targets in liver disease and cancer.